As Co-Founder and Chief Scientific Officer of Frezent Biological Solutions, Lina Freage-Kahn leverages her expertise in antibody discovery, immunotherapeutics, and biomolecular design. A PhD graduate from The Hebrew University of Jerusalem, she focuses on translating scientific research into real-world applications and biotech strategy.
She developed a novel immunotherapy assay using engineered DNA aptamers to activate T-cells and NK cells, which established a new research branch during her postdoctoral fellowship.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.